Effect of glucagon-like peptide-1 receptor agonists on circulating levels of leptin and resistin: A meta-analysis of randomized controlled trials
A few other friction points: For a variety of reasons, Indians haven't taken to GLP-1s with the same enthusiasm as Western populations
Quek LE, van Geldermalsen M, Guan YF, Wahi K, Mayoh C, Balaban S, et al
Subsequently, liraglutide (Saxenda) was approved in 2014 for the treatment of obesity up to a maximum dose of 3.0 mg subcutaneously once daily in people with a BMI 30 kg/m 2 , or 27 kg/m 2 and obesity-related co-morbidity [9, 17]
found that senior dogs had significantly higher medication compliance rates